Testing suvorexant for insomnia in people with opioid use disorder
Treatments studied
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether the sleep medication suvorexant (Belsomra) can help people with opioid use disorder who also have trouble sleeping. If you are stable on medication for opioid use disorder and have not used opioids in the last month, this trial may be an option for you.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with opioid use disorder and are on a stable dose of medication to treat it (like methadone or buprenorphine).
- You have chronic trouble sleeping (insomnia) for at least a month.
- You have not taken any opioid drugs for at least 4 weeks before the study starts.
- You do not have other serious sleep disorders (like sleep apnea, restless legs, or narcolepsy) or an unstable mental health condition.
- Your usual bedtime is between 8 PM and 1 AM, and you can keep that schedule during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether the sleep medication suvorexant can help people with both alcohol use disorder and PTSD. If you're struggling with drinking, PTSD symptoms, and poor sleep, this trial may offer a new treatment option.
This study tests whether the sleep medication suvorexant can improve insomnia in veterans who also have post-traumatic stress disorder (PTSD). It aims to see if treating sleep helps with PTSD symptoms.
This study tests if the sleep medication lemborexant can help people with opioid use disorder who also have chronic insomnia. Participants must already be taking buprenorphine (Suboxone) for at least 4 weeks. The goal is to see if better sleep improves mood and reduces opioid use.
This study tests a new sleep medication (an orexin antagonist) to see if it helps Veterans with PTSD overcome fear and sleep better. It aims to improve how your brain handles fear responses.
This study tests a sleep medication called daridorexant to see if it helps people with both insomnia and alcohol use disorder sleep better and reduce drinking. It may offer a new way to address both problems together.
This study tests an experimental sleep aid called daridorexant for people who have both depression and insomnia. It aims to see if the drug can improve sleep without worsening depression symptoms.
Hear when a new Insomnia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.